Page 7 - பார்கின்சன் படிப்பு குழு நிர்வாகி குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பார்கின்சன் படிப்பு குழு நிர்வாகி குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பார்கின்சன் படிப்பு குழு நிர்வாகி குழு Today - Breaking & Trending Today

5 Transit Stations Worth Seeing

© Joe Ravi/Dreamstsime.com
Transit stations are often a place to be passed through on the way to somewhere else. Several, though, are notable enough to warrant a visit.
Earlier versions of the descriptions of these transit stations first appeared in 1001 Amazing Places You Must See Before You Die
, edited by Richard Cavendish (2016). Writers’ names appear in parentheses.
Union Station (Toronto, Canada)
Even to the jaded 21st-century eye, the facade of Toronto’s Union Station is still vast and magnificent in its cool proportions, classy decorative stone, and refined Beaux-Arts lines. Monumental it certainly is, because it occupies an entire city block on the south side of Front Street between York and Bay streets. It also recalls a past era of train travel when passengers passing through the lobby could detour to the station’s barbershop and even baths. ....

New York , United States , United Kingdom , Grand Central Terminal , Victoria Terminus , Los Angeles , Frederick Williams Stevens , Lucinda Hawksley , James Harrison , Tamsin Pickeral , Joe Ravi Dreamstsime , Mary Coulter , Richard Cavendish , Ashim Paun , Jules Alexis Coutan , Yul Brynner , Warren Wetmore , John Lyle , Canadian Pacific Railway , Siberian Railroad , Trunk Railway , Los Angeles Union Passenger Terminal , Union Pacific , Bombay School Of Art , Chhatrapati Shivaji Terminus , Union Station ,

Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea

Eisai to Launch Parkinson s Disease Treatment Equfina in South Korea
TOKYO, Feb 1, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that Eisai Korea Inc., Eisai s subsidiary in South Korea, has launched the Parkinson s disease treatment Equfina (safinamide mesilate, safinamide ). This is the first launch of Equfina in the Asian region excluding Japan.
The estimated number of patients with Parkinson s disease is approximately 150,000 in South Korea. Parkinson s disease has high unmet medical needs because of inadequate symptom control using current medications, necessitating new treatment options. This disease is designated as a rare intractable disease in South Korea.
The marketing approval of this drug in South Korea is primarily based on a double-blind, placebo-controlled, Phase III Study (SETTLE study) conducted overseas (including South Korea) to evaluate the efficacy and safety of 24-week oral administration of the once-daily safinamide as an add-on to lev ....

United States , Hong Kong , Republic Of , South Korea , E Ray Dorsey , Japanese Society Of Neurology Parkinson , Newron Pharmaceuticals , Eisai Co Ltd , Public Relations Department , Eisai Korea Inc , Meiji Seika Pharma Co Ltd , Japan Intractable Diseases Information Center , Levodopa Adjunct , Patients With Parkinson Disease , Motor Fluctuations , Randomized Clinical , Global Burden , Disease Study , Japanese Society , Relations Department , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , குடியரசு ஆஃப் , தெற்கு கொரியா , ஏ ராய் டோர்ஸி , ஜப்பானிய சமூகம் ஆஃப் நரம்பியல் பார்கின்சன் ,

Invitation to presentation of BioArctic's Full Year Report for the period January - December 2020 on February 4 at 9.30 a.m. CET

Invitation to presentation of BioArctic s Full Year Report for the period January - December 2020 on February 4 at 9.30 a.m. CET
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B)
will publish the company s Full Year Report for the period January - December 2020 on
Thursday, February 4, 2021, at 08:00 a.m. CET.
In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on February 4, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the Full Year Report for the period January - December 2020, followed by a Q&A-session.
To attend, please dial-in at one of the numbers below, from: ....

United Kingdom , Uppsala Lan , Oskar Bosson , Parkinson Abbvie , Jan Mattsson , Gunilla Osswald , Uppsala University , Vp Communications , Nasdaq Stockholm , Full Year Report , Investor Relations , Nasdaq Stockholm Mid Cap , ஒன்றுபட்டது கிஂக்டம் , வ்ப் தகவல்தொடர்புகள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , முழு ஆண்டு அறிக்கை , முதலீட்டாளர் உறவுகள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் நடுவில் தொப்பி ,

BioArctic receives European patent for new antibodies targeting Alzheimer's disease

BioArctic receives European patent for new antibodies targeting Alzheimer s disease
STOCKHOLM, Jan. 27, 2021 /PRNewswire/
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the European Patent Office (EPO) has issued a decision to grant European patent EP 2 448 968 B1 for novel antibodies that could be developed into a treatment for Alzheimer s disease. The antibodies target a shorter (truncated) form of amyloid beta (pE3-Aß) and are linked to the company s project AD1503. The patent enters into force on 27 January 2021 and expires in 2030.
BioArctic s newly granted patent focuses on novel antibodies which target pE3-Ab, a specific truncated form of amyloid beta. Monomers of pE3-Ab are highly prone to aggregate, leading to the formation of harmful soluble Ab aggregates which cause debilitating cognitive and other symptoms in Alzheimer s disease. ....

Uppsala Lan , Oskar Bosson , Parkinson Abbvie , Gunilla Osswald , Uppsala University , European Patent Office , Nasdaq Stockholm , Vice President Communications , Investor Relations , Nasdaq Stockholm Mid Cap , ஐரோப்பிய காப்புரிமை அலுவலகம் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , துணை ப்ரெஸிடெஂட் தகவல்தொடர்புகள் , முதலீட்டாளர் உறவுகள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் நடுவில் தொப்பி ,

Invitation to presentation of BioArctic's Full Year Report for the period January - December 2020 on February 4 at 9.30 a.m. CET

/PRNewswire/ BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company s Full Year Report for the period January - December 2020 on Thursday,. ....

United Kingdom , Uppsala Lan , Oskar Bosson , Parkinson Abbvie , Jan Mattsson , Gunilla Osswald , Uppsala University , Vp Communications , Nasdaq Stockholm , Full Year Report , Investor Relations , Nasdaq Stockholm Mid Cap , ஒன்றுபட்டது கிஂக்டம் , வ்ப் தகவல்தொடர்புகள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , முழு ஆண்டு அறிக்கை , முதலீட்டாளர் உறவுகள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் நடுவில் தொப்பி ,